About RTI
Home » About RTI
RTI at a Glance
RTI Biologics, Inc. is a leader in tissue-based innovations
that are used to repair and promote the natural healing of human bone and
other human tissues. RTI processes human and animal musculoskeletal
tissues in producing allograft and xenograft implants. Surgeons then use these
implants to repair a wide variety of bone and other tissue defects, including
spinal vertebrae repair, musculoskeletal reconstruction, fracture repair,
joint repair and reconstruction for sports medicine injuries.
The source of all allograft is tissue that has been donated by people upon
their death, with the consent of their family or loved ones. RTI honors the
gift of tissue donation by treating the tissue with respect, by finding new
ways to use the tissue to help patients and by helping as many patients as
possible from each donation.
RTI’s Sterling® line of xenograft implants is derived from bovine
bone that comes from a certified closed and organic herd of cattle raised
for pharmaceutical use. RTI has a longstanding, exclusive agreement with a
self-sustaining agricultural operation that promotes strong environmental
philosophies, holistic management practices and humane treatment of livestock.
Both allograft and xenograft implants are sterilized through RTI's patented
BioCleanse® Tissue Sterilization Process. BioCleanse® is the only proven tissue sterilization process validated to eliminate
viruses, bacteria, fungi and spores from the tissue without compromising the
biocompatibility or structural integrity of the implant. RTI is the only company
in the industry using this sterilization process, which has been reviewed
by the FDA.
RTI is committed to being the leader in science, safety and
innovation in the natural healing of patients using biological materials and
through leading technologies, such as the BioCleanse Tissue Sterilization Process.